Roadshow presentation factsFacts that should make you run away from this deal
1) Livwell is forecasting 0 grams of dried flower sold in 2019 beacuse 51st facility isn't even built yet and all they have is land and a license in process along with 1665 other companies as of May 17th (
Health Canada Applicant Stats)
2) Target Capital, is run by the same group that runs 51st and the same group that will be running Livwell is issuing 51st shareholders 1.4 billion shares which is equivalent to paying $140 million based on TCI's share price of $0.10/share, for a company with no license, no facility and no prospects of making sales until 2020.
Market cap based on the current deal structure is $350 million on completiong of the financing. Good luck with supporting that. Stock will barely support a $75 million valuation in my oppinion and deal crooks will blow out their shares all the way down and leave the retarded retail investors holding the bag.
Hate to say it again, but pass on this deal and buy GTEC instead if you want exposure to a junior Cannabis player